• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透明质酸修饰的 Zein-PEG 纳米粒用于 SKOV3 卵巢癌细胞中紫杉醇的递送。

Zein-PEG nanoparticles modified with hyaluronic acid for paclitaxel delivery in SKOV3 ovarian cancer cells.

机构信息

School of Pharmacy, College of Medicine, National Taiwan University, Taipei 10050, Taiwan.

School of Pharmacy, College of Medicine, National Taiwan University, Taipei 10050, Taiwan; Drug Research Center, College of Medicine, National Taiwan University, Taipei 10050, Taiwan.

出版信息

Int J Biol Macromol. 2024 Nov;281(Pt 4):136651. doi: 10.1016/j.ijbiomac.2024.136651. Epub 2024 Oct 16.

DOI:10.1016/j.ijbiomac.2024.136651
PMID:39423978
Abstract

Ovarian cancer is a leading gynecological cancer globally. This study aimed to develop hyaluronic acid-modified polyethylene glycol conjugated zein nanoparticles (zein-PEG/HA NPs) to enhance paclitaxel (PTX) cytotoxicity in SKOV3 ovarian cancer cells. Zein-PEG, with its amphiphilic nature, self-assembled into micelles to encapsulate the hydrophobic PTX, while the PEG shell retained micelle stability and hemolytic resistance. PTX@zein-PEG micelles (17.2 ± 0.3 mV) were complexed with negatively charged HA through electrostatic interactions, resulting in PTX@zein-PEG/HA NPs with a negative zeta potential of -15.3 ± 1.1 mV. Cellular uptake of fluorescent zein-PEG/HA NPs was higher than zein-PEG micelles in CD44-overexpressing SKOV3 cells. Additionally, PTX@zein-PEG/HA NPs demonstrated significantly greater cytotoxicity than free PTX and PTX@zein-PEG micelles, with IC values reduced by 6.13-fold and 3.58-fold, respectively. PTX@zein-PEG/HA NPs induced the highest expression levels of apoptotic proteins, particularly PARP, in SKOV3 cells compared to PTX@zein-PEG NPs and free PTX. In summary, PTX@zein-PEG/HA NPs demonstrated potential as a delivery system for PTX in ovarian cancer.

摘要

卵巢癌是全球主要的妇科癌症。本研究旨在开发透明质酸修饰的聚乙二醇偶联玉米醇溶蛋白纳米粒(zein-PEG/HA NPs),以增强 SKOV3 卵巢癌细胞中紫杉醇(PTX)的细胞毒性。玉米醇溶蛋白具有两亲性,自组装成胶束以包裹疏水性的 PTX,而 PEG 壳则保持胶束的稳定性和抗溶血能力。PTX@zein-PEG 胶束(17.2±0.3 mV)通过静电相互作用与带负电荷的 HA 复合,形成负 zeta 电位为-15.3±1.1 mV 的 PTX@zein-PEG/HA NPs。在 CD44 过表达的 SKOV3 细胞中,荧光标记的 zein-PEG/HA NPs 的细胞摄取量高于 zein-PEG 胶束。此外,PTX@zein-PEG/HA NPs 对 SKOV3 细胞的细胞毒性明显大于游离 PTX 和 PTX@zein-PEG 胶束,IC 值分别降低了 6.13 倍和 3.58 倍。PTX@zein-PEG/HA NPs 在 SKOV3 细胞中诱导的凋亡蛋白表达水平,尤其是 PARP,明显高于 PTX@zein-PEG NPs 和游离 PTX。综上所述,PTX@zein-PEG/HA NPs 有望成为卵巢癌中 PTX 的递送系统。

相似文献

1
Zein-PEG nanoparticles modified with hyaluronic acid for paclitaxel delivery in SKOV3 ovarian cancer cells.透明质酸修饰的 Zein-PEG 纳米粒用于 SKOV3 卵巢癌细胞中紫杉醇的递送。
Int J Biol Macromol. 2024 Nov;281(Pt 4):136651. doi: 10.1016/j.ijbiomac.2024.136651. Epub 2024 Oct 16.
2
Improved paclitaxel delivery with PEG-b-PLA/zein nanoparticles prepared via flash nanoprecipitation.通过闪式纳米沉淀法制备的 PEG-b-PLA/zein 纳米粒提高紫杉醇的递送。
Int J Biol Macromol. 2022 Nov 30;221:486-495. doi: 10.1016/j.ijbiomac.2022.09.021. Epub 2022 Sep 7.
3
Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.用于紫杉醇递送以克服耐药性的卵巢癌靶向透明质酸纳米粒子系统。
Drug Deliv. 2016 Jun;23(5):1810-7. doi: 10.3109/10717544.2015.1101792. Epub 2015 Nov 4.
4
Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model.由透明质酸-紫杉醇共轭物自组装而成的载有游离紫杉醇的E-选择素结合肽修饰的胶束可抑制小鼠模型中的乳腺癌转移。
Int J Pharm. 2017 Aug 7;528(1-2):33-46. doi: 10.1016/j.ijpharm.2017.05.063. Epub 2017 May 31.
5
Paclitaxel-Loaded Mixed Micelles Enhance Ovarian Cancer Therapy through Extracellular pH-Triggered PEG Detachment and Endosomal Escape.载紫杉醇混合胶束通过细胞外pH触发的聚乙二醇脱离和内体逃逸增强卵巢癌治疗效果。
Mol Pharm. 2016 Jul 5;13(7):2411-22. doi: 10.1021/acs.molpharmaceut.6b00164. Epub 2016 Jun 20.
6
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.载紫杉醇和 FAK siRNA 的靶向 CD44 的 PLGA 纳米粒克服上皮性卵巢癌的化疗耐药性。
Cancer Res. 2018 Nov 1;78(21):6247-6256. doi: 10.1158/0008-5472.CAN-17-3871. Epub 2018 Aug 16.
7
"OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.“OA02”肽有助于紫杉醇载药胶束纳米粒在体内精准靶向卵巢癌。
Cancer Res. 2012 Apr 15;72(8):2100-10. doi: 10.1158/0008-5472.CAN-11-3883. Epub 2012 Mar 6.
8
Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer.揭示熊果酸修饰透明质酸纳米粒在三阴性乳腺癌联合药物治疗中的潜力。
Carbohydr Polym. 2024 Aug 15;338:122196. doi: 10.1016/j.carbpol.2024.122196. Epub 2024 Apr 24.
9
Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer.透明质酸修饰的 PLGA-PEG 纳米粒用于载 SN-38 的靶向递药系统治疗卵巢癌
Anticancer Res. 2013 Jun;33(6):2425-34.
10
A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.一种用于卵巢癌中紫杉醇递送的自组装纳米颗粒。
Biomaterials. 2009 Oct;30(30):6006-16. doi: 10.1016/j.biomaterials.2009.07.015. Epub 2009 Aug 5.